The immune response of BALB/c mice to a pathogenic and nonpathogenic strains of influenza type A virus was studied. In this system of experimental influenza infection the pathogenic influenza A/PR8/34 (HON1) virus was found to induce sensitization of T-lymphocytes and production of clones cytotoxic for syngeneic target cells. Nonpathogenic influenza A/Krasnodar/101/59 (H2N2) virus had a less marked capacity to induce sensitization of lymphocytes and production of clones cytotoxic for syngeneic target cells. But the nonpathogenic virus strain had a sufficiently high mitogenic activity and stimulated proliferation of lymphocytes sensitized by a heterogenous influenza virus strain.

Download full-text PDF

Source

Publication Analysis

Top Keywords

induce sensitization
8
production clones
8
clones cytotoxic
8
cytotoxic syngeneic
8
syngeneic target
8
target cells
8
cells nonpathogenic
8
virus strain
8
influenza
5
virus
5

Similar Publications

Background: Ferroptosis is a recently studied form of programmed cell death characterized by lipid peroxides accumulation in the cells. This process occurs when a cell's antioxidant capacity is disturbed resulting in the inability of the cell to detoxify the toxic peroxides. Two major components that regulate ferroptosis are cysteine and iron.

View Article and Find Full Text PDF

Comprehensive Cellular Senescence Evaluation to Aid Targeted Therapies.

Research (Wash D C)

January 2025

State Key Laboratory of Genetic Engineering, National Clinical Research Center for Aging and Medicine, Huashan Hospital, Collaborative Innovation Center of Genetics and Development, Human Phenome Institute, Center for Evolutionary Biology, Shanghai Engineering Research Center of Industrial Microorganisms, School of Life Sciences, Fudan University, Shanghai 200438, China.

Drug resistance to a single agent is common in cancer-targeted therapies, and rational drug combinations are a promising approach to overcome this challenge. Many Food and Drug Administration-approved drugs can induce cellular senescence, which possesses unique vulnerabilities and molecular signatures. However, there is limited analysis on the effect of the combination of cellular-senescence-inducing drugs and targeted therapy drugs.

View Article and Find Full Text PDF

Targeting MXD1 sensitises pancreatic cancer to trametinib.

Gut

January 2025

State Key Laboratory of Oncology in South China and Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

Background: The resistance of pancreatic ductal adenocarcinoma (PDAC) to trametinib therapy limits its clinical use. However, the molecular mechanisms underlying trametinib resistance in PDAC remain unclear.

Objective: We aimed to illustrate the mechanisms of resistance to trametinib in PDAC and identify trametinib resistance-associated druggable targets, thus improving the treatment efficacy of trametinib-resistant PDAC.

View Article and Find Full Text PDF

Coralyne (COR) is a protoberberine-like isoquinoline alkaloid, and it is known for double-stranded (ds) DNA intercalation and topoisomerase inhibition. It can also sensitize cancer cells through various mechanisms. COR reduces the proliferation and migration of breast cancer cells by inhibiting the expression and activity of matrix metalloproteinase 9 (MMP9).

View Article and Find Full Text PDF

Background: Nitric oxide (NO) is a low-toxicity and high-efficiency anticancer treatment that can augment the cytotoxicity of doxorubicin (DOX) towards breast cancer cells, thereby exhibiting a favorable effect on chemotherapy sensitization.

Objective: The study aimed to establish a hydrogel that sensitizes chemotherapy by inducing local inflammatory stimulation to change the tumor microenvironment and promote NO production. The purpose of the study was to examine the anti-tumor effect in vivo and in vitro.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!